← Back to Search

LEAD IT! programming for Alzheimer's Disease

Phase 2
Recruiting
Research Sponsored by Hearthstone Alzheimer Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment--that is during week 23 thru week 24.
Awards & highlights
No Placebo-Only Group

Summary

This trial involves the LEAD IT! app, a tablet-based application designed to help people with early-stage dementia lead group activities for their peers. The target population is individuals with early-stage dementia living in long-term care facilities. The app aims to provide these individuals with a sense of purpose and improve their engagement by enabling them to guide structured activities.

Eligible Conditions
  • Alzheimer's Disease
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment--that is during week 23 thru week 24.
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment--that is during week 23 thru week 24. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dementia Related Quality of Life
Dementia Related Quality of Life (DEMQOL)
Menorah Park Engagement Scale
Secondary study objectives
Cohen Mansfield Agitation Inventory
Geriatric Depression Scale-Short Form
Neuropsychiatric Inventory-Nursing Home

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental, LEAD IT! ProgrammingExperimental Treatment1 Intervention
Participants in the Experimental / LEAD IT! arm will take part in LEAD IT! programming for 18 weeks. The programming will occur twice per week, for a total of 36 sessions.
Group II: Control, Standard Care / ProgrammingActive Control1 Intervention
Participants in the Control arm will receive standard care / programming.

Find a Location

Who is running the clinical trial?

Hearthstone Alzheimer CareLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
~35 spots leftby Nov 2025